Acute kidney injury in heart failure: a population study.
Acute kidney injury
Heart failure
Renal function
Risk of hospitalization
Risk of mortality
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
23
07
2019
revised:
08
11
2019
accepted:
25
11
2019
pubmed:
15
2
2020
medline:
22
6
2021
entrez:
15
2
2020
Statut:
ppublish
Résumé
The objective of the present study is to assess the prognostic value of acute kidney injury (AKI) in the evolution of patients with heart failure (HF) using real-world data. Patients with a diagnosis of HF and with serial measurements of renal function collected throughout the study period were included. Estimated glomerular filtration rate (GFR) was calculated with the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). AKI was defined when a sudden drop in creatinine with posterior recovery was recorded. According to the Risk, Injury, Failure, Loss, and End-Stage Renal Disease (RIFLE) scale, AKI severity was graded in three categories: risk [1.5-fold increase in serum creatinine (sCr)], injury (2.0-fold increase in sCr), and failure (3.0-fold increase in sCr or sCr > 4.0 mg/dL). AKI incidence and risk of hospitalization and mortality after the first episode were calculated by adjusting for potential confounders. A total of 30 529 patients with HF were included. During an average follow-up of 3.2 years, 5294 AKI episodes in 3970 patients (13.0%) and incidence of 3.3/100 HF patients/year were recorded. One episode was observed in 3161 (10.4%), two in 537 (1.8%), and three or more in 272 (0.9%). They were more frequent in women with diabetes and hypertension. The incidence increases across the GFR levels (Stages 1 to 4: risk 7.6%, 6.8%, 11.3%, and 12.5%; injury 2.1%, 2.0%, 3.3%, and 5.5%; and failure 0.9%, 0.6%. 1.4%, and 8.0%). A total of 3817 patients with acute HF admission were recorded during the follow-up, with incidence of 38.4/100 HF patients/year, 3101 (81.2%) patients without AKI, 545 (14.3%) patients with one episode, and 171 (4.5%) patients with two or more. The number of AKI episodes [one hazard ratio (HR) 1.05 (0.98-1.13); two or more HR 2.01 (1.79-2.25)] and severity [risk HR 1.05 (0.97-1.04); injury HR 1.41 (1.24-1.60); and failure HR 1.90 (1.64-2.20)] increases the risk of hospitalization. A total of 10 560 deaths were recorded, with incidence of 9.3/100 HF patients/year, 8951 (33.7%) of subjects without AKI episodes, 1180 (11.17%) of subjects with one episode, and 429 (4.06%) with two or more episodes. The number of episodes [one HR 1.05 (0.98-1.13); two or more HR 2.01 (1.79-2.25)] and severity [risk 1.05 confidence interval (CI) (0.97-1.14), injury 1.41 (CI 1.24-1.60), and failure 1.90 (CI 1.64-2.20)] increases mortality risk. The study demonstrated the worse prognostic value of sudden renal function decline in HF patients and pointed to those with more future risk who require review of treatment and closer follow-up.
Identifiants
pubmed: 32059081
doi: 10.1002/ehf2.12595
pmc: PMC7160477
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
415-422Subventions
Organisme : Carlos III Health Institute
ID : PI16/01402
Pays : International
Organisme : BigMedilytics
ID : ICT-15-780495
Pays : International
Organisme : BigData@Heart
ID : IMI2-FPP116074-2
Pays : International
Informations de copyright
© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
Références
JAMA. 2007 Nov 7;298(17):2038-47
pubmed: 17986697
J Cardiol. 2010 May;55(3):317-21
pubmed: 20350524
Eur Heart J. 2014 Feb;35(7):455-69
pubmed: 24164864
Clin Biochem Rev. 2016 May;37(2):85-98
pubmed: 28303073
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):554-61
pubmed: 25649155
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
ESC Heart Fail. 2020 Apr;7(2):415-422
pubmed: 32059081
Nat Rev Cardiol. 2016 Jan;13(1):28-35
pubmed: 26370473
J Card Fail. 2007 Aug;13(6):422-30
pubmed: 17675055
Crit Care. 2019 Jan 24;23(1):24
pubmed: 30678696
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):833-841
pubmed: 29773712
J Am Coll Cardiol. 2014 Sep 16;64(11):1106-13
pubmed: 25212644
Int Heart J. 2012;53(5):313-9
pubmed: 23038093
Int J Cardiol. 2018 Jan 1;250:215-222
pubmed: 29050923
Int J Cardiol. 2017 Apr 1;232:208-215
pubmed: 28087182
Nat Rev Nephrol. 2016 Oct;12(10):610-23
pubmed: 27573728
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nephrology (Carlton). 2018 Mar;23(3):237-246
pubmed: 27990707
Eur J Heart Fail. 2010 Jan;12(1):32-7
pubmed: 20023042
J Am Coll Cardiol. 2006 May 16;47(10):1987-96
pubmed: 16697315
Curr Heart Fail Rep. 2018 Aug;15(4):224-238
pubmed: 29987499